Anthracyclines News and Research

RSS
Herceptin drugs for breast cancer linked with increased risk of congestive heart failure

Herceptin drugs for breast cancer linked with increased risk of congestive heart failure

MedUni Vienna researchers identify reason for chemoresistance in small cell lung cancer

MedUni Vienna researchers identify reason for chemoresistance in small cell lung cancer

PharmaMar begins PM184 Phase II trial in advanced breast cancer patients

PharmaMar begins PM184 Phase II trial in advanced breast cancer patients

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Study sheds light on clinical and biological characteristics of male breast cancer

Study sheds light on clinical and biological characteristics of male breast cancer

Combination therapy benefits patients with acute myeloid leukemia

Combination therapy benefits patients with acute myeloid leukemia

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

Update Pharma's UPI-928 gets FDA orphan drug designation for AML treatment

Update Pharma's UPI-928 gets FDA orphan drug designation for AML treatment

Study could lead towards a personalised medicine for chemoresistant lymphomata

Study could lead towards a personalised medicine for chemoresistant lymphomata

New drug combination therapy effective for patients with HER2-positive breast cancer

New drug combination therapy effective for patients with HER2-positive breast cancer

Cell Therapeutics presents preclinical study results of PIXUVRI at AACR-NCI-EORTC meeting

Cell Therapeutics presents preclinical study results of PIXUVRI at AACR-NCI-EORTC meeting

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Cancer patients who receive chest radiation should screen for heart disease every 5-10 years

Cancer patients who receive chest radiation should screen for heart disease every 5-10 years

Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years

Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years